Key Event Details

  • Event: Allotment of equity shares under ESOP 2019
  • Date of Committee Meeting: August 11, 2026
  • Date of Share Issue: August 11, 2026
  • Regulatory Reference: Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021

Share Allotment Details

  • Number of shares allotted: 31,250 equity shares
  • Face value: Re. 1/- per share
  • Exercise price: ₹43 per share
  • Premium per share: ₹42 per share
  • Distinctive numbers: 10,62,43,973 to 10,62,75,222 (both inclusive)

Capital Structure Impact

  • Previous paid-up share capital: 10,62,43,973 equity shares aggregating ₹10,62,43,973
  • New paid-up share capital: 10,62,75,222 equity shares aggregating ₹10,62,75,222
  • Increase in share capital: 31,249 shares (₹31,249)

Lock-in and Share Characteristics

  • Lock-in period: 6 months from date of allotment
  • Lock-in expiry date: February 10, 2027
  • Share status: The allotted shares will rank pari passu with existing equity shares
  • Listing fees: Not applicable

Plan Background

  • ESOP Plan Name: Bliss GVS Pharma Limited-Employee Stock Option Plan, 2019
  • Previous filings: Statement filed with stock exchanges on February 14, 2020
  • Application numbers: BSE - 106063, NSE - 23188
  • In-principle approval: BSE: DCS/FL/DS/ESOP-IP/542/2019-20 dated February 27, 2020; NSE: NSE/LIST/23188 dated March 04, 2020